1-(4-Fluoro-benzyl)-6-[5-(4-methyl-piperazine-1-sulfonyl)-2-propoxy-phenyl]-1,7-dihydro-imidazo[4,5-g]quinazolin-8-one

ID: ALA342527

Chembl Id: CHEMBL342527

PubChem CID: 135528172

Max Phase: Preclinical

Molecular Formula: C30H31FN6O4S

Molecular Weight: 590.68

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1nc(O)c2cc3c(cc2n1)ncn3Cc1ccc(F)cc1

Standard InChI:  InChI=1S/C30H31FN6O4S/c1-3-14-41-28-9-8-22(42(39,40)37-12-10-35(2)11-13-37)15-24(28)29-33-25-17-26-27(16-23(25)30(38)34-29)36(19-32-26)18-20-4-6-21(31)7-5-20/h4-9,15-17,19H,3,10-14,18H2,1-2H3,(H,33,34,38)

Standard InChI Key:  PQCMYGIPHHYBHN-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA342527

    ---

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 3 and 5 (PDE3 and PDE5) (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 4 and 5 (PDE4 and PDE5) (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 590.68Molecular Weight (Monoisotopic): 590.2112AlogP: 4.26#Rotatable Bonds: 8
Polar Surface Area: 113.68Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.39CX Basic pKa: 5.99CX LogP: 5.15CX LogD: 5.14
Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.29Np Likeness Score: -1.72

References

1. Rotella DP, Sun Z, Zhu Y, Krupinski J, Pongrac R, Seliger L, Normandin D, Macor JE..  (2000)  Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitors.,  43  (26): [PMID:11150175] [10.1021/jm000336j]

Source